| Name | Title | Contact Details |
|---|
For over 100 years the name Viking has represented global leadership in fire protection. We lead the industry in quality and innovation because fire protection is all we do, and our single focus is to support and enhance the efforts of independent fire sprinkler contractors. We believe that protecting people and property from fire transcends the bottom line, and we never stop asking "what do our customers need to be successful?" Today, The Viking Group provides independent fire sprinkler contractors with integrated solutions for any fire protection challenge. Rely on Viking to deliver: Unmatched Quality: Our reputation has been earned by focusing on continuous improvement in all elements of our business – from the products we manufacture to the services we provide. Product Breadth: The largest selection of fixed fire protection products and services ensures single-point solutions for any fire protection challenge. Experienced Support: Knowledgeable customer service and technical support at every point in the project process. Innovation that Matters: From valves that are easier to install and maintain, to automated fabrication capabilities, Viking innovates to solve problems and strengthen your business. Everywhere You Need Us: With our global network of independent distribution partners and dozens of locations, Vikings products and services are available when and where you need them.
Providing real-time asset tracking in any environment, with applications in manufacturing, defense, energy, inventory management, logistics, and security. WISERs ultra-wideband (UWB) system operates without line-of-sight and registers asset locations within inches in most cases.
LFI specializes in the sale and service of contemporary furnishings to public, private, school, and academic libraries. By meeting the rapidly changing sociological and technological changes through design and product, LFI has become the Midwests leading library furnishing company.
At VMG Health, were more than just a team of experts; were trusted partners in the business of healthcare. Backed by a team of over 300 professionals and a history of more than 70,000 engagements since 1995, we bring experience deep and wide to every project. Our national client base ranges from large health systems to small practices and everything in between, including investors and private equity firms. Our solutions-oriented approach to client needs is bolstered by our strong market position, extensive contacts, unparalleled tools and solutions, and expert insights. We are proud to serve as the single source for all our clients valuation, strategic, and compliance needs. At VMG Health, we make healthcare business performance personal.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.